Feasibility Testing of a Hospice Family Caregiver Intervention to Improve Patient Dyspnea Care
Primary Purpose
Dyspnea
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Shortness of breath recognition and treatment
Sponsored by
About this trial
This is an interventional treatment trial for Dyspnea
Eligibility Criteria
Inclusion Criteria:
- Patient in home hospice care with an estimated survival of 3-4 weeks, at risk for dyspnea secondary to lung cancer, COPD, or heart failure.
- Family caregiver in patient's home must speak and read English.
Exclusion Criteria:
- Patients with bulbar ALS or quadriplegia.
Sites / Locations
- Angela Hospice
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Intervention
Arm Description
all participants will receive the training
Outcomes
Primary Outcome Measures
Change in patient respiratory comfort
The Respiratory Distress Observation Scale will be used to measure patient respiratory comfort at enrollment (baseline), twice each week during the study until patient death.
Secondary Outcome Measures
Family caregiver burden index
The Modified Caregiver Strain Index
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02441868
Brief Title
Feasibility Testing of a Hospice Family Caregiver Intervention to Improve Patient Dyspnea Care
Official Title
Feasibility Testing of a Hospice Family Caregiver Intervention to Improve Patient Dyspnea Care
Study Type
Interventional
2. Study Status
Record Verification Date
April 2018
Overall Recruitment Status
Completed
Study Start Date
October 15, 2015 (Actual)
Primary Completion Date
April 30, 2018 (Actual)
Study Completion Date
April 30, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Wayne State University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study is a pilot test of an intervention to train family caregivers of home hospice patients about recognizing and treating shortness of breath.
Detailed Description
Shortness of breath is a prevalent symptom causing distress among patients at the end of life. In home hospice care family caregivers are expected to assist their family member with symptom management. This is often accomplished with little or no training.
The investigators have developed a bundle of training materials targeted for family caregivers of home hospice patients at risk for shortness of breath. The investigators will pilot test the intervention in this clinical trial. A future randomized clinical trial is planned and the evidence from this pilot will enhance the planning of that future trial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dyspnea
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
7 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
all participants will receive the training
Intervention Type
Behavioral
Intervention Name(s)
Shortness of breath recognition and treatment
Intervention Description
Hospice registered nurses will train family caregivers about how to recognize patient shortness of breath. This training will employ a guided learning tool the Respiratory Distress Observation Scale-Family. Training will be done with a DVD and return demonstration of the skills using the patient. In addition, the family will be taught the bundle of evidence-based interventions to treat shortness of breath.
Primary Outcome Measure Information:
Title
Change in patient respiratory comfort
Description
The Respiratory Distress Observation Scale will be used to measure patient respiratory comfort at enrollment (baseline), twice each week during the study until patient death.
Time Frame
Baseline and up to four weeks until patient death
Secondary Outcome Measure Information:
Title
Family caregiver burden index
Description
The Modified Caregiver Strain Index
Time Frame
Baseline and participants will be followed for an average of 4 weeks until date of death
Other Pre-specified Outcome Measures:
Title
Family caregiver stress as measured by Salivary cortisol
Description
Salivary cortisol
Time Frame
Baseline and participants will be followed for an average of four weeks to end at time of death.
Title
Family anxiety questionnaire
Description
Promis anxiety Short form
Time Frame
Baseline and participants will be followed for an average of four weeks to end at time of death
Title
Family depression questionnaire
Time Frame
Baseline and participants will be followed for an average of four weeks to end at time of death
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient in home hospice care with an estimated survival of 3-4 weeks, at risk for dyspnea secondary to lung cancer, COPD, or heart failure.
Family caregiver in patient's home must speak and read English.
Exclusion Criteria:
Patients with bulbar ALS or quadriplegia.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Margaret L. Campbell, PhD
Organizational Affiliation
Wayne State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Angela Hospice
City
Livonia
State/Province
Michigan
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Feasibility Testing of a Hospice Family Caregiver Intervention to Improve Patient Dyspnea Care
We'll reach out to this number within 24 hrs